Skip to main content

Blogs to Boards: Question 7


This is the seventh in a series of 41 posts from both GeriPal and Pallimed to get our physician readers ready for the hospice and palliative medicine boards. Every week GeriPal and Pallimed alternates publishing a new question, as well as a discussion of possible answers to the question (click here for the full list of questions).  


Question 7

JY, a 28 year old woman with advanced cystic fibrosis and Burkholderia cenocepacia colonization is hospitalized for a cystic fibrosis exacerbation. She has chronic chest wall pain from coughing and pleurisy, and recently broke 2 ribs from coughing. She is on IV glucocorticoids, IV ketorolac, IV ketamine prior to vest treatments, and lorazepam.

Prior to her hospitalization, she took oxycodone ER 30mg q12h. Currently she is on a hydromorphone IV PCA at 2mg/hour, with 2mg q30 minute boluses. She used 72mg of IV dilaudid in the last 24h. Despite this she is becoming drowsy, and reports her pain is minimally improved and still severe for most of the day: 7-8/10, and ‘nearly intolerable’ during vest therapy

The best next step is to:

a) Increase her PCA basal and ‘bolus’ doses by 50% and monitor for 24 hours. 
b) Add a 5% lidocaine patch to her chest wall over her rib fractures 
c) Discontinue hydromorphone and switch the patient to another opioid 
d) Advise the primary team to stop vest therapies 


Discussion:

Comments

Anonymous said…
I would change the agent and add the lidocaine TDP.Taht she is already drowsy without pain relief is discouraging.Hold the vest therapy for a day or two while changing the agent and see whether pain relief is better and sputum clearance any decreased and then decide on the frequency to as tolerated.
Bruce Scott MD said…
I guess we should try opioid rotation (IV fentanyl? methadone?)

Who is managing the ketamine? Was it working previously and now has stopped? If it is dosed properly, then it probably means that a rotation strategy to methadone will be less likely to be successful that we are otherwise used to. (Ketamine is a considerbly more potent NMDA recepter antagonist than methadone.)

I'd really be more inclined to increase the ketamine dose if she is not having side effects.

I agree with the first (anonymous) commenter that it is tempting to try skipping a day or two of the percussion vest therapy. I think that the primary team (or pulmonology) is unlikely to love this plan, however.

While topical lidocaine may not be terribly useful here, some might try IV lidocaine prior to vest therapy if the IV ketamine isn't working. My own sample size with IV lidocaine is small and results disappointing.
john.rich16 said…
I would keep all this in my mind while dealing with the patients so thanks to share this information here in your blog.

Home care

Popular posts from this blog

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Opening the Black Box of LTACs: Podcast with Anil Makam

What happens in Long Term Acute Care Hospitals, or LTACs (pronounced L-tacs)?  I've never been in one.  I've sent patients to them - usually patients with long ICU stays, chronically critically ill, with a gastric feeding tube and a trach for ventilator support.  For those patients, the goals (usually as articulated by the family) are based on a hope for recovery of function and a return home.

And yet we learn some surprising things from Anil Makam, Assistant Professor of Medicine at UCSF.  In his JAGS study of about 14,000 patients admitted to LTACHs, the average patient spent two thirds of his or her remaining life in an institutional settings (including hospitals, LTACs and skilled nursing facilities).  One third died in an LTAC, never returning home.

So you would think with this population of older people with serious illness and a shorter prognosis than many cancers, we would have robust geriatrics and palliative care in LTACs?  Right? Wrong.

3% were seen by a geriatrici…

Length of Stay in Nursing Homes at the End of Life

One out of every four of us will die while residing in a nursing home. For most of us, that stay in a nursing home will be brief, although this may depend upon social and demographic variables like our gender, net worth, and marital status. These are the conclusions of an important new study published in JAGS by Kelly and colleagues (many of whom are geripal contributors, including Alex Smith and Ken Covinsky).

The study authors used data from the Health and Retirement Study (HRS) to describe the lengths of stay of older adults who resided in nursing homes at the end of life. What they found was that out of the 8,433 study participants who died between 1992 and 2006, 27.3% of resided in a nursing home prior to their death. Most of these patients (70%) actually died in the nursing home without being transferred to another setting like a hospital.

 The length of stay data were striking:

the median length of stay in a nursing home before death was 5 months the average length of stay was l…